You are here

lung cancer

We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated

San Francisco Gate, CA

Sun, 04/15/18 - 10:04 pm

Bristol-Myers Squibb

non-small cell lung cancer

Qiagen launches liquid biopsy tests for lung, prostate cancer

Drug Delivery Business News

Sat, 04/14/18 - 12:43 pm

prostate cancer

Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Biopharma Dive

Sat, 04/14/18 - 12:35 pm

With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace

Xconomy

Wed, 04/11/18 - 09:53 am

immuno-oncology

Visiongate Announces Next Step in Commercialization of Cancer Detection Platform

CP Wire

Fri, 04/6/18 - 11:42 am

LuCED Lung Test

Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib

Endpoints

Wed, 04/4/18 - 10:51 am

priority review

Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week

Fierce Pharma

Mon, 03/26/18 - 10:37 pm

Roche's Tecentriq cocktail notches another lung cancer success

Yahoo/Reuters

Mon, 03/26/18 - 09:38 am

clinical trials

Is AbbVie 'Unraveling' In Solid Tumor Market After Drug Misstep?

Investors Business Daily

Sat, 03/24/18 - 09:10 am

Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer

Xconomy

Fri, 03/23/18 - 09:37 pm

robotic surgery

Is It Game Over for AbbVie's Promising Cancer Drug?

Motley Fool

Thu, 03/22/18 - 10:21 pm

AbbVie says not seeking accelerated approval for lung cancer drug

Yahoo/Reuters

Thu, 03/22/18 - 09:07 am

accelerated approvals

FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market

Endpoints

Sat, 02/17/18 - 10:44 am

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial

Yahoo/Reuters

Thu, 02/15/18 - 10:09 am

clinical trials

Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment

Forbes

Mon, 02/5/18 - 11:58 am

Merck's Keytruda extends lung cancer survival in combination trial

Yahoo/Reuters

Tue, 01/16/18 - 10:01 am

clinical trials

Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst

Fierce Pharma

Sat, 12/9/17 - 02:22 pm

Roche's Tecentriq combo cuts risk of lung cancer progression

BioPharma Dive

Thu, 12/7/17 - 11:44 pm

Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early

Endpoints

Fri, 12/1/17 - 09:32 am

Bristol-Myers Squibb

Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer

Xconomy

Mon, 11/20/17 - 09:40 am

Pages